Suppr超能文献

肝肾综合征

Hepatorenal syndrome.

作者信息

Turban Sharon, Thuluvath Paul J, Atta Mohamed G

机构信息

Division of Nephrology, Johns Hopkins University, 1830 East Monument Street, Suite 416, Baltimore, Maryland 21205, USA.

出版信息

World J Gastroenterol. 2007 Aug 14;13(30):4046-55. doi: 10.3748/wjg.v13.i30.4046.

DOI:10.3748/wjg.v13.i30.4046
PMID:17696221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4205304/
Abstract

Hepatorenal syndrome (HRS) is a "functional" and reversible form of renal failure that occurs in patients with advanced chronic liver disease. The distinctive hallmark feature of HRS is the intense renal vasoconstriction caused by interactions between systemic and portal hemodynamics. This results in activation of vasoconstrictors and suppression of vasodilators in the renal circulation. Epidemiology, pathophysiology, as well as current and emerging therapies of HRS are discussed in this review.

摘要

肝肾综合征（HRS）是一种发生在晚期慢性肝病患者中的“功能性”且可逆的肾衰竭形式。HRS的显著标志性特征是全身和门静脉血流动力学相互作用导致的强烈肾血管收缩。这导致肾循环中血管收缩剂的激活和血管扩张剂的抑制。本文综述了HRS的流行病学、病理生理学以及当前和新出现的治疗方法。

相似文献

1
Hepatorenal syndrome.肝肾综合征
World J Gastroenterol. 2007 Aug 14;13(30):4046-55. doi: 10.3748/wjg.v13.i30.4046.
2
The management of hepatorenal syndrome.肝肾综合征的管理
Minerva Gastroenterol Dietol. 2009 Jun;55(2):207-26.
3
The hepatorenal syndrome.肝肾综合征
Med Clin North Am. 2008 Jul;92(4):813-37, viii-ix. doi: 10.1016/j.mcna.2008.03.007.
4
Pathophysiology, clinical features and management of hepatorenal syndrome.肝肾综合征的病理生理学、临床特征及管理
Eur Rev Med Pharmacol Sci. 1998 Sep-Dec;2(5-6):181-4.
5
[Hepatorenal syndrome - pathophysiology, diagnosis and treatment].[肝肾综合征——病理生理学、诊断与治疗]
Vnitr Lek. 2015 Jul-Aug;61(7-8):649-54.
6
Recent advances in our understanding of hepatorenal syndrome.我们对肝肾综合征认识的最新进展。
Nat Rev Gastroenterol Hepatol. 2012 May 22;9(7):382-91. doi: 10.1038/nrgastro.2012.96.
7
Hepatorenal syndrome.肝肾综合征
Semin Liver Dis. 1997;17(3):233-47. doi: 10.1055/s-2007-1007201.
8
Hepatorenal syndrome.肝肾综合征
Dig Dis. 2005;23(1):47-55. doi: 10.1159/000084725.
9
[Therapy of hepatorenal syndrome].[肝肾综合征的治疗]
Praxis (Bern 1994). 1997 Jan 21;86(4):102-3.
10
Hepatorenal syndrome.肝肾综合征
Forum (Genova). 1998 Jan-Mar;8(1):62-81.

引用本文的文献

1
Refractory Ascites: Pathogenesis, Clinical Impact, and Management.顽固性腹水：发病机制、临床影响及管理
Gastroenterol Hepatol (N Y). 2009 Sep;5(9):647-656.
2
Acute-on-chronic liver failure: recent update.慢加急性肝衰竭：近期进展
J Biomed Res. 2017 Jul 13;31(4):283-300. doi: 10.7555/JBR.30.20160060.

本文引用的文献

1
The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.血管收缩剂在肝硬化患者中的应用：1型肝肾综合征及其他情况
Hepatology. 2006 Mar;43(3):385-94. doi: 10.1002/hep.21094.
2
Impact of pretransplant renal failure: when is listing for kidney-liver indicated?移植前肾衰竭的影响：何时适合列入肝肾联合移植名单？
Liver Transpl. 2005 Nov(11 Suppl 2):S35-44. doi: 10.1002/lt.20617.
3
Circulatory function and hepatorenal syndrome in cirrhosis.肝硬化中的循环功能与肝肾综合征
Hepatology. 2005 Aug;42(2):439-47. doi: 10.1002/hep.20766.
4
Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study.血管加压素而非奥曲肽可能对肝肾综合征的治疗有益：一项回顾性研究。
Nephrol Dial Transplant. 2005 Sep;20(9):1813-20. doi: 10.1093/ndt/gfh930. Epub 2005 Jun 14.
5
Transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术
Dig Dis. 2005;23(1):56-64. doi: 10.1159/000084726.
6
The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.奥曲肽与奥曲肽联合米多君长期治疗对非氮质血症性肝硬化腹水患者全身血流动力学、肾血流动力学及肾功能的影响。
Am J Gastroenterol. 2005 Apr;100(4):879-85. doi: 10.1111/j.1572-0241.2005.40899.x.
7
Hepatorenal syndrome: a dreaded complication of end-stage liver disease.肝肾综合征：终末期肝病的一种可怕并发症。
Am J Gastroenterol. 2005 Feb;100(2):460-7. doi: 10.1111/j.1572-0241.2005.40952.x.
8
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?哪些患者能从肝肾综合征的血液透析治疗中获益？
J Gastroenterol Hepatol. 2004 Dec;19(12):1369-73. doi: 10.1111/j.1440-1746.2004.03471.x.
9
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.米多君、奥曲肽、白蛋白及经颈静脉肝内门体分流术用于特定肝硬化合并1型肝肾综合征患者
Hepatology. 2004 Jul;40(1):55-64. doi: 10.1002/hep.20262.
10
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.肝移植前肝肾综合征治疗对移植后结局的影响。一项病例对照研究。
J Hepatol. 2004 Jan;40(1):140-6. doi: 10.1016/j.jhep.2003.09.019.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验